Association between Non-High-Density-Lipoprotein-Cholesterol Levels and the Prevalence of Asymptomatic Intracranial Arterial Stenosis

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Wu, Jianwei ^a   Zhang, Qian ^a,b   Yang, Huajun ^a   Gao, Xiang ^c,d   Zhou, Yong ^a   Wang, Anxin ^a   Wang, Chunxue ^a   Zhang, Shufeng ^b   Wu, Shouling ^e   Zhao, Xingquan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b GENERAL HOSPITAL OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e HEBEI UNITED UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ASYMPTOMATIC DISEASE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OCCLUSIVE CEREBROVASCULAR DISEASE; PREDICTION; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

CHINA; CHOLESTEROL, HDL; CONSTRICTION, PATHOLOGIC; FEMALE; HUMANS; INTRACRANIAL ARTERIAL DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84878426389     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065229     Document Type: Article

References (34)

1. Wong KS, Huang YN, Gao S, Lam WW, Chan YL, et al. (1998) Intracranial stenosis in Chinese patients with acute stroke. Neurology 50: 812-813.
2. Wong KS, Li H, (2003) Long-term mortality and recurrent stroke risk among Chinese stroke patients with predominant intracranial atherosclerosis. Stroke 34: 2361-2366.
3. Feldmann E, Daneault N, Kwan E, Ho KJ, Pessin MS, et al. (1990) Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology 40: 1541-1545.
4. Wong KS, Ng PW, Tang A, Liu R, Yeung V, et al. (2007) Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients. Neurology 68: 2035-2038.
5. Du YL, Chen SX, Hu YR, Lu XH, Qian WQ, et al. (2007) [Prevalence and risk factors of asymptomatic intracranial vascular stenosis in patients with essential hypertension]. Zhonghua Xin Xue Guan Bing Za Zhi 35: 893-896.
6. Sacco RL, Kargman DE, Zamanillo MC, (1995) Race-ethnic differences in stroke risk factors among hospitalized patients with cerebral infarction: the Northern Manhattan Stroke Study. Neurology 45: 659-663.
7. Ingall TJ, Homer D, Baker HL Jr, Kottke BA, O'Fallon WM, et al. (1991) Predictors of intracranial carotid artery atherosclerosis. Duration of cigarette smoking and hypertension are more powerful than serum lipid levels. Arch Neurol 48: 687-691.
8. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
9. Mahajan N, Ference BA, Arora N, Madhavan R, Bhattacharya P, et al. (2012) Role of non-high-density lipoprotein cholesterol in predicting cerebrovascular events in patients following myocardial infarction. Am J Cardiol 109: 1694-1699.
10. Ren J, Zhao D, Liu J, Wang W, Wang M, et al. (2010) [Relationship between serum non-high-density lipoprotein cholesterol and incidence of cardiovascular disease]. Zhonghua Xin Xue Guan Bing Za Zhi 38: 934-938.
11. Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, et al. (2005) Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation 112: 3375-3383.
12. Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan L, et al. (2007) Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA 298: 776-785.
13. Liu J, Sempos CT, Donahue RP, Dorn J, Trevisan M, et al. (2006) Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. Am J Cardiol 98: 1363-1368.
14. Robinson JG, Wang S, Jacobson TA, (2012) Meta-analysis of comparison of effectiveness of lowering apolipoprotein B versus low-density lipoprotein cholesterol and nonhigh-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trials. Am J Cardiol 110: 1468-1476.
15. Wu S, Huang Z, Yang X, Zhou Y, Wang A, et al. (2012) Prevalence of ideal cardiovascular health and its relationship with the 4-year cardiovascular events in a northern Chinese industrial city. Circ Cardiovasc Qual Outcomes 5: 487-493.
16. Kayamori Y, Hatsuyama H, Tsujioka T, Nasu M, Katayama Y, (1999) Endpoint colorimetric method for assaying total cholesterol in serum with cholesterol dehydrogenase. Clin Chem 45: 2158-2163.
17. Bachorik PS, Ross JW, (1995) National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. Clin Chem 41: 1414-1420.
18. Bucolo G, David H, (1973) Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19: 476-482.
19. Bittner V, (2003) Non-high-density lipoprotein cholesterol and cardiovascular disease. Curr Opin Lipidol 14: 367-371.
20. Deeg R, Kraemer W, Ziegenhorn J, (1980) Kinetic determination of serum glucose by use of the hexokinase/glucose-6-phosphate dehydrogenase method. J Clin Chem Clin Biochem 18: 49-52.
21. Wong KS, Huang YN, Yang HB, Gao S, Li H, et al. (2007) A door-to-door survey of intracranial atherosclerosis in Liangbei County, China. Neurology 68: 2031-2034.
22. Celermajer DS, Chow CK, Marijon E, Anstey NM, Woo KS, (2012) Cardiovascular disease in the developing world: prevalences, patterns, and the potential of early disease detection. J Am Coll Cardiol 60: 1207-1216.
23. Gao S, Lam WW, Chan YL, Liu JY, Wong KS, (2002) Optimal values of flow velocity on transcranial Doppler in grading middle cerebral artery stenosis in comparison with magnetic resonance angiography. J Neuroimaging 12: 213-218.
24. Assessment: transcranial Doppler. Report of the American Academy of Neurology, Therapeutics and Technology Assessment Subcommittee. Neurology 40: 680-681.
25. Tsivgoulis G, Vadikolias K, Heliopoulos I, Katsibari C, Voumvourakis K,et al. (2012) Prevalence of Symptomatic Intracranial Atherosclerosis in Caucasians: A Prospective, Multicenter, Transcranial Doppler Study. J Neuroimaging.
26. Arenillas JF, Molina CA, Montaner J, Abilleira S, Gonzalez-Sanchez MA, et al. (2001) Progression and clinical recurrence of symptomatic middle cerebral artery stenosis: a long-term follow-up transcranial Doppler ultrasound study. Stroke 32: 2898-2904.
27. Meseguer E, Lavallee PC, Mazighi M, Labreuche J, Cabrejo L, et al. (2010) Yield of systematic transcranial Doppler in patients with transient ischemic attack. Ann Neurol 68: 9-17.
28. Wu S, Huang Z, Yang X, Zhou Y, Wang A, et al. (2012) Prevalence of ideal cardiovascular health and its relationship with the 4-year cardiovascular events in a northern Chinese industrial city. Circ Cardiovasc Qual Outcomes 5: 487-493.
29. Kim YS, Hong JW, Jung WS, Park SU, Park JM, et al. (2011) Gender differences in risk factors for intracranial cerebral atherosclerosis among asymptomatic subjects. Gend Med 8: 14-22.
30. Kim BS, Jung HS, Bang OY, Chung CS, Lee KH, et al. (2010) Elevated serum lipoprotein(a) as a potential predictor for combined intracranial and extracranial artery stenosis in patients with ischemic stroke. Atherosclerosis 212: 682-688.
31. Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, et al. (2008) Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care 31: 811-822.
32. de Kleijn MJ, van der Schouw YT, Verbeek AL, Peeters PH, Banga JD, et al. (2002) Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women. Am J Epidemiol 155: 339-345.
33. Kublickiene K, Luksha L, (2008) Gender and the endothelium. Pharmacol Rep 60: 49-60.
34. Miller AA, Drummond GR, Mast AE, Schmidt HH, Sobey CG, (2007) Effect of gender on NADPH-oxidase activity, expression, and function in the cerebral circulation: role of estrogen. Stroke 38: 2142-2149.